Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bron
Clinical trial register · France

Clinical Trials in Bron, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Paris 41 Lille 38 Lyon 35 Marseille 34 Montpellier 32
Narrow the registerReset
Recruitment status
Phase
Site location
Paris41 Lille38 Lyon35 Marseille34 Montpellier32
All 69 locations
Target enrolment
to

Trials with a site in Bron

15 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Hoffmann-La Roche
Phase 3
138
Le Kremlin-Bicêtre, Bron, Lille
2026-05-15
Recruiting
Hoffmann-La Roche
Phase 3
360
Le Kremlin-Bicêtre, Bron, Lille, Paris
2026-04-27
Recruiting
Hoffmann-La Roche
Phase 3
900
Marseille, Bron, Clermont-Ferrand, Créteil, La Tronche, Lille, Limoges, Montpellier
2025-11-24
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Amiens Cedex1, Bordeaux, Bron, Limoges, Montpellier, Paris, Saint-Herblain, Strasbourg
2025-11-12
Recruiting
Hoffmann-La Roche
Phase 3
500
Amiens Cedex1, Bayonne, Besançon, Bordeaux, Brest, Bron, Caen, Clermont-Ferrand
2024-12-13
Active, closed
Hoffmann-La Roche
Phase 3
338
Brest, Bron, Lille, Lyon, Montpellier, Nice, Paris, Pessac
2024-09-23
Active, closed
Hoffmann-La Roche
Phase 2
256
Bron, Lille, Marseille, Paris, Rouen, Saint-Herblain, Strasbourg, Toulouse
2024-05-02
Active, closed
Hoffmann-La Roche
Phase 3
139
Bron, Le Kremlin-Bicêtre
2022-08-30
Active, closed
Hoffmann-La Roche
Phase 3
188
Bron, Le Kremlin-Bicêtre, Montpellier, Strasbourg
2022-05-19
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Caen, Nancy, Bordeaux, Bron, Clermont-Ferrand, Lille, Nice, Poissy
2022-05-03
Active, closed
Hoffmann-La Roche
Phase 2
586
Bordeaux, Bron, Clermont-Ferrand, Créteil, Grenoble, Limoges, Marseille, Montpellier
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
985
Bordeaux, Bron, Montpellier, Nantes, Nice, Strasbourg
2020-10-26
Active, closed
Hoffmann-La Roche
Phase 3
927
Bayonne, Bordeaux, Bron, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier
2018-05-28
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 November 2026. https://priyalifescience.com/clinical-trials-france/city/bron

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Bron that also match the filters currently applied.

How many clinical trials are recruiting in Bron?

5 of the 15 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bron), 15 studies
PhaseStudiesRecruitingShare
Phase 313586.7%
Phase 22013.3%

Most active sponsors

Lead sponsors with the most studies (Bron)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche155
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.